This site provides INTERCEPT product information for Canada audiences. Select your region

The INTERCEPT Blood System for Plasma and Platelets is approved in Canada. 

The INTERCEPT Blood System for plasma is intended to be used for the ex vivo preparation of pathogen-reduced, whole blood derived or apheresis plasma. The INTERCEPT Blood System for platelets is intended for the ex vivo treatment and storage of platelet components. The system is used to inactivate a broad range of pathogens, including viruses, bacteria, and protozoan parasites, thus reducing the risk of transfusion-transmitted infections (TTI).

Press Releases:

Package Inserts:

Contact Us:

Phone: 1.855.835.3523
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.